Healthcare provider profile · identity verified

Matthew David Rathbun, NP

Nurse Practitioner · EVERGREEN PARK, IL · NPI 1184239667

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	770	143
Amlodipine Besylate	Amlodipine Besylate	697	137
Metformin Hcl	Metformin Hcl	337	64
Losartan Potassium	Losartan Potassium	317	70
Lisinopril	Lisinopril	311	69
Gabapentin	Gabapentin	297	54
Pantoprazole Sodium	Pantoprazole Sodium	294	51
Furosemide	Furosemide	266	51
Metoprolol Succinate	Metoprolol Succinate	226	45
Levothyroxine Sodium	Levothyroxine Sodium	216	36
Tamsulosin Hcl	Tamsulosin Hcl	215	39
Metoprolol Tartrate	Metoprolol Tartrate	214	38
Omeprazole	Omeprazole	202	29
Trazodone Hcl	Trazodone Hcl	187	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	183	36
Eliquis	Apixaban	181	32
Hydrochlorothiazide	Hydrochlorothiazide	153	39
Albuterol Sulfate Hfa	Albuterol Sulfate	149	36
Potassium Chloride	Potassium Chloride	144	28
Simvastatin	Simvastatin	144	28
Donepezil Hcl	Donepezil Hcl	139	15
Carvedilol	Carvedilol	136	35
Nifedipine Er	Nifedipine	125	27
Sertraline Hcl	Sertraline Hcl	120	13
Escitalopram Oxalate	Escitalopram Oxalate	117	19
Duloxetine Hcl	Duloxetine Hcl	103	suppressed
Mirtazapine	Mirtazapine	95	13
Chlorthalidone	Chlorthalidone	87	16
Hydralazine Hcl	Hydralazine Hcl	83	25
Clopidogrel	Clopidogrel Bisulfate	82	16
Famotidine	Famotidine	80	12
Tramadol Hcl	Tramadol Hcl	78	20
Jardiance	Empagliflozin	77	11
Allopurinol	Allopurinol	76	19
Januvia	Sitagliptin Phosphate	76	suppressed
Xarelto	Rivaroxaban	76	suppressed
Enalapril Maleate	Enalapril Maleate	74	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	73	16
Meclizine Hcl	Meclizine Hcl	73	12
Levetiracetam	Levetiracetam	71	16
Alprazolam	Alprazolam	68	16
Olanzapine	Olanzapine	67	suppressed
Atenolol	Atenolol	59	suppressed
Ozempic	Semaglutide	57	suppressed
Baclofen	Baclofen	55	suppressed
Montelukast Sodium	Montelukast Sodium	54	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	54	12
Clonidine Hcl	Clonidine Hcl	52	suppressed
Divalproex Sodium	Divalproex Sodium	50	suppressed
Memantine Hcl	Memantine Hcl	49	suppressed
Paroxetine Hcl	Paroxetine Hcl	48	suppressed
Digoxin	Digoxin	47	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	46	22
Trulicity	Dulaglutide	45	suppressed
Fluticasone Propionate	Fluticasone Propionate	44	19
Risperidone	Risperidone	44	suppressed
Meloxicam	Meloxicam	43	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	43	suppressed
Lorazepam	Lorazepam	42	suppressed
Finasteride	Finasteride	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	39	suppressed
Amantadine	Amantadine Hcl	38	suppressed
Ezetimibe	Ezetimibe	37	suppressed
Bumetanide	Bumetanide	36	suppressed
Spironolactone	Spironolactone	36	11
Torsemide	Torsemide	34	suppressed
Farxiga	Dapagliflozin Propanediol	33	11
Ibuprofen	Ibuprofen	32	16
Alendronate Sodium	Alendronate Sodium	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Mounjaro	Tirzepatide	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Amiodarone Hcl	Amiodarone Hcl	30	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Lovastatin	Lovastatin	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Benztropine Mesylate	Benztropine Mesylate	29	suppressed
Glipizide	Glipizide	28	suppressed
Topiramate	Topiramate	27	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Glipizide Er	Glipizide	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Prednisone	Prednisone	23	13
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Tradjenta	Linagliptin	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	22	suppressed
Fenofibrate	Fenofibrate,micronized	21	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Azithromycin	Azithromycin	15	15
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Oxcarbazepine	Oxcarbazepine	15	suppressed
Phenytoin	Phenytoin	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Brilinta	Ticagrelor	14	suppressed
Exemestane	Exemestane	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Naproxen	Naproxen	14	suppressed
Niacin Er	Niacin	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	13	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	13	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Primidone	Primidone	13	suppressed
Rivastigmine	Rivastigmine Tartrate	13	suppressed
Valsartan	Valsartan	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error